Efficacy/cost ratio of new therapy.
Fiel
S B
SB
D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis / Q000188:drug therapy*; D003850:Deoxyribonuclease I / Q000191:economics* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I